|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 35/74 | (2015.01) |
| A61K 39/085 | (2006.01) | ||
| A61K 39/39 | (2006.01) | ||
| C07K 14/31 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3122378 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15711523.9 |
| Date of filing the European patent application | 2015-03-24 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-11 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (86) | Number | PCT/EP2015/056175 |
| Date | 2015-03-24 |
| (87) | Number | WO 2015/144653 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| 14161861 | 2014-03-26 | EP | |
| 14192913 | 2014-11-12 | EP |
| (72) |
BAGNOLI, Fabio, IT
FIASCHI, Luigi, IT
SCARSELLI, Maria, IT
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Mutantų stafilokokiniai antigenai |
| MUTANT STAPHYLOCOCCAL ANTIGENS |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 10 | 231.00 EUR |
| 2025-03-24 |